In their debut trading on Friday, September 25 Prelude Therapeutics showed a 37.89 % raise and closed at $26.20 per share. Shortly before the company placed its shares in an IPO priced $19 per share.
Заполните форму и наш специалист свяжется с вами в ближайшее время для уточнения деталей